• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

Recent Advances in the Study of Methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate (CAS: 155884-24-5)

Methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate (CAS: 155884-24-5) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, biological activities, and potential therapeutic uses, making it a compound of interest for researchers in the pharmaceutical industry.

One of the key areas of research has been the optimization of synthetic routes for methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate. A study published in the Journal of Organic Chemistry (2023) demonstrated an efficient, one-pot synthesis method using readily available starting materials, which significantly improved the yield and purity of the compound. This advancement is expected to facilitate further pharmacological studies and scale-up production for potential clinical applications.

In terms of biological activity, methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate has shown promising results as a scaffold for the development of novel antimicrobial agents. A recent in vitro study highlighted its inhibitory effects against a range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The compound's mechanism of action appears to involve disruption of bacterial cell wall synthesis, although further mechanistic studies are needed to confirm this hypothesis.

Additionally, computational modeling studies have suggested that methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate may interact with specific protein targets involved in inflammatory pathways. This has led to preliminary investigations into its potential as an anti-inflammatory agent, with early-stage in vivo studies showing reduced cytokine production in animal models of inflammation. However, these findings are still in the exploratory phase, and more rigorous preclinical testing is required.

From a drug development perspective, researchers have also explored the pharmacokinetic properties of methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate. A 2024 study reported favorable absorption and distribution profiles in rodent models, with moderate metabolic stability. These findings suggest that the compound could be a viable candidate for further optimization to improve its drug-like properties.

Despite these promising developments, challenges remain in the research of methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate. Current limitations include the need for more comprehensive toxicity studies and the exploration of structure-activity relationships to enhance its potency and selectivity. Future research directions may focus on derivatization of the core structure to expand its therapeutic potential.

In conclusion, methyl 2-(propan-2-yl)-1,3-oxazole-4-carboxylate represents an interesting chemical entity with multiple potential applications in medicinal chemistry. The recent advancements in its synthesis and biological evaluation provide a solid foundation for future drug discovery efforts. As research progresses, this compound may emerge as a valuable tool for addressing unmet medical needs in areas such as infectious diseases and inflammation.

• 1060814-30-3(2-isopropyloxazol-4-yl propionate)
• 140381-02-8(4-Oxazolecarboxylic acid, 2-[2-(methoxymethoxy)-1-methylethyl]-,methyl ester, (R)-)
• 1060816-06-9(ethyl 2-tert-butyloxazole-4-carboxylate)
• 1060816-08-1(2-tert-butyl-1,3-oxazole-4-carboxylic acid)
• 153180-21-3(2-(propan-2-yl)-1,3-oxazole-4-carboxylic acid)
• 140381-01-7(4-Oxazolecarboxylic acid, 2-butyl-, methyl ester)
• 1060816-03-6(Ethyl 2-Cyclopropyl-1,3-oxazole-4-carboxylate)
• 75395-42-5(2-ethyl-1,3-oxazole-4-carboxylic acid)
• 85806-67-3(Methyl 2-methyloxazole-4-carboxylate)
• 1060816-04-7(2-cyclopropyl-1,3-oxazole-4-carboxylic acid)